# CMB.TECH NV (CMBT) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Industrials / Marine. Price $19.49, market value $5.7 billion.

## Valuation
- **P/E (trailing): 6.6×** (5-yr avg 6.9×, 3-yr avg 6.0×). CMB.TECH NV trades at 6.6× trailing earnings, close to its own five-year average of 6.9×. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 12.6×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 2.5×**. Each dollar of revenue is priced at 2.5×.
- **Price / book: 1.8×**. The shares trade at 1.8× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 7.8×**. Enterprise value is 7.8× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 5.3%** (5-yr avg -28.0%). Free cash flow equals 5.3% of the market value, above its five-year average of -28.0%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 15.2%**. The inverse of the P/E: 15.2% of the price is earned each year.

## Profitability
- **Gross margin: 36.5%**. CMB.TECH NV keeps 36.5% of revenue after the direct cost of what it sells.
- **Operating margin: 32.2%**. 32.2% of revenue is left after running the business, an exceptional level.
- **Net margin: 9.6%**. 9.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 6.1%**. 6.1% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.0%**. Return on all capital, debt included, is 9.0%.
- **Return on assets: 10.0%**. Each dollar of assets produces 10.0% of profit.

## Growth
- **Revenue growth (1 yr): 77.2%** (3-yr 24.9%/yr, 5-yr 6.6%/yr). Revenue grew 77.2% over the last year, against 6.6% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -84.2%** (3-yr -11.5%/yr, 5-yr -20.8%/yr). Earnings per share fell 84.2%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 2.12**. Debt is 2.12 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 3.8×**. It would take 3.8 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: 2.1×**. Operating profit covers interest 2.1×, thin but manageable.
- **Current ratio: 0.86** (quick 0.79). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.35**. A Z-score of 1.35 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 4.10%** ($0.85 per share, trailing). CMB.TECH NV yields 4.10%, an income-level yield.
- **Payout ratio: 13%**. 13% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): -53.8%/yr** (1-yr -99.4%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover CMB.TECH NV; the consensus is buy, with an average price target of $20.25 (+4% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 127.7%** (YTD 113.3%, 3-mo 31.9%). The shares are up 127.7% over twelve months including dividends.
- **From 52-week high: -0.6%** (119.6% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 77**. An RSI of 77 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.39** (volatility 41%). Beta of 0.39 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CMBT · Page: https://foliofundamentals.com/stocks/cmbt

Not investment advice.